Citius Oncology Gets Nasdaq Extension to Meet Nasdaq Bid Price Rule
Citius Oncology received an extension through April 19, 2027, to regain compliance with Nasdaq’s $1.00 minimum bid price requirement.
Citius Oncology received an extension through April 19, 2027, to regain compliance with Nasdaq’s $1.00 minimum bid price requirement.